Drawing for EYRISIC

USPTO serial 87123070

EYRISIC

Reviewed by CopyMark Law Group

Reg. 5151217Status 710
Filing date
Status date
Registration date
Feb 28, 2017
Examiner
HACK, ANDREA R
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with EYRISIC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher M. Hanes

Christopher M. Hanes GSK410 Blackwell StreetLegal Brand ProtectionDurham, NC 27701

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disordersSECTION 8 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 8, 2023C8..CANCELLED SEC. 8 (6-YR)
Nov 8, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 8, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 8, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 8, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 8, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 8, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 8, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 28, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 28, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 13, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 13, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 23, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 30, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 29, 2016DOCKASSIGNED TO EXAMINER
Aug 4, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 4, 2016NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance